KALA BIO, INC. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- KALA BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-12-31 was -$1.00K.
- KALA BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2025-09-30 was $7.00K, a 22.22% decline year-over-year.
- KALA BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-12-31 was $0.00.
- KALA BIO, INC. stock issued during period, value, stock options exercised for the quarter ending 2024-09-30 was $9.00K.
- KALA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2025 was $6.00K, a 33.33% decline from fiscal 2024.
- KALA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2024 was $9.00K.
- KALA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- KALA BIO, INC. stock issued during period, value, stock options exercised for fiscal 2022 was $3.00K, a 98.79% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $6.00K 10-K · filed 2026-04-15 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-19 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $9.00K 10-K · filed 2026-04-15 |
| 2024-09-30 | $9.00K 10-Q · filed 2025-11-19 | |
| 2023-12-31 | $0.00 10-K · filed 2024-03-29 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $3.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $3.00K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $3.00K derived: sum of 4 quarters · filed 2023-08-04 |
| 2022-03-31 | $3.00K 10-Q · filed 2023-05-09 | $67.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $248.00K 10-K · filed 2023-03-03 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $390.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $64.00K 10-Q · filed 2022-08-11 | $397.00K derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $184.00K 10-Q · filed 2022-05-16 | $1.10M derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $1.09M 10-K · filed 2022-03-29 |
| 2020-09-30 | $7.00K 10-Q · filed 2021-11-15 | $946.00K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $772.00K 10-Q · filed 2021-08-05 | $942.00K derived: sum of 4 quarters · filed 2021-08-05 |
| 2020-03-31 | $167.00K 10-Q · filed 2021-05-05 | $170.00K derived: sum of 4 quarters · filed 2021-05-05 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $42.00K 10-K · filed 2021-02-25 |
| 2019-09-30 | $3.00K 10-Q · filed 2020-11-05 | $281.00K derived: sum of 4 quarters · filed 2020-11-05 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $391.00K derived: sum of 4 quarters · filed 2020-08-06 |
| 2019-03-31 | $39.00K 10-Q · filed 2020-05-07 | $541.00K derived: sum of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | $239.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $530.00K 10-K · filed 2020-02-12 |
| 2018-09-30 | $113.00K 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $150.00K 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $28.00K 10-Q · filed 2019-05-09 | |
| 2017-12-31 | $423.00K 10-K · filed 2019-03-12 | |
| 2015-12-31 | $104.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |